참고문헌
- Adercal I, Moser CD, Veerasamy M, et al (2008). The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. J Hepatol, 49, 373-83. https://doi.org/10.1016/j.jhep.2008.05.015
- Aqeilan RI, Donati V, Palamarchuk A, et al (2005). WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res, 65, 6764-72. https://doi.org/10.1158/0008-5472.CAN-05-1150
- Aqeilan RI, Donati V, Gaudio E, et al (2007). Association of Wwox with ErbB4 in breast cancer. Cancer Res, 67, 9330-6. https://doi.org/10.1158/0008-5472.CAN-07-2147
- Aravalli RN, Steer CJ, and Cressman EN (2008). Molecular mechanisms of hepatocellular carcinoma. Hepatology, 48, 2047-63. https://doi.org/10.1002/hep.22580
- Abdeen SK, Salah Z, Maly B, et al (2011). Wwox inactivation enhances mammary tumorigenesis. Oncogene, 30, 3900-6. https://doi.org/10.1038/onc.2011.115
- Chang JY, He RY, Lin HP, et al (2010). Signaling from membrane receptors to tumor supressor WW domain-containing oxidoreductase. Exp Biol Med, 235, 796-804. https://doi.org/10.1258/ebm.2010.009351
- Chang NS, Doherty J, Ensign A (2003). JNK1 physically interacts with WW domain-cotaining oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J Biol Chem, 278, 9195-202. https://doi.org/10.1074/jbc.M208373200
- Chen ST, Chuang JI, Cheng CL, et al (2005). Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domaincontaining oxidoreductase in vivo. Neuroscience, 130, 397-407. https://doi.org/10.1016/j.neuroscience.2004.07.054
- Coleman WB. (2003) Mechanism of human hepatocarcinogenesis. Curr Mol Med, 3, 573-88. https://doi.org/10.2174/1566524033479546
- Del MS, Salah Z, Aqeilan RI (2009). WWOX: its genomics, partners, and functions. J Cell Biochem, 108, 737-45. https://doi.org/10.1002/jcb.22298
- Gourley C, Paige A, Taylor KJ, et al (2009). WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Res, 69, 4835-42. https://doi.org/10.1158/0008-5472.CAN-08-2974
- Guler G, Uner A, Guler N, et al (2003). The Fragile Genes FHIT and WWOX Are Inactivated Coordinately in Invasive Breast Carcinoma. Cancer, 100.
- Huan J, Zheng DL, Qin FS, et al (2010). Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling. J Clin Invest, 120, 223-41. https://doi.org/10.1172/JCI38012
- Hong Q, Sze Ci, Lin SR, et al (2009). Complement C1q activates tumor suppressor WWOX to induce aopotosis in prostate cancer cells. PloS One, 4, e5755. https://doi.org/10.1371/journal.pone.0005755
-
Kallin A, Johannessen LE, Cani PD, et al (2007). SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55
${\gamma}$ . J Lipid Res, 48, 1628-36. https://doi.org/10.1194/jlr.M700136-JLR200 - Kurek KC, Del Mare S, Salah Z, et al (2010). Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. Cancer Res, 70, 5577-86. https://doi.org/10.1158/0008-5472.CAN-09-4602
- Kim TM, Yim SH, Shin SH, et al (2008). Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer, 123, 2808-15. https://doi.org/10.1002/ijc.23901
- Ludes-Meyers JH, Kil H, Bednarek AK, et al (2004). WWOX binds the specific proline-rich ligand PPXY: identification of candidate interanting proteins. Oncogene, 23, 5049-55. https://doi.org/10.1038/sj.onc.1207680
- Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Salah Z, Aqeilan R and Huebner K (2010). WWOX gene and gene product tumor suppression through specific protein interactions. Future Oncol, 6, 249-59. https://doi.org/10.2217/fon.09.152
- Teng CC, Yang YT, Chen YC, et al (2012). Role of WWOX/ WOX1 in Alzheimer's disease pathology and in cell death signaling. Front Biosci (Elite Ed), 4, 1951-65.
- Wang JS, Huang T, Su J, et al (2001). Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarkers Prev, 10, 143-6.
- Wong N, Chan A, Lee SW, et al (2003). Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes overexpression. J Hepatol, 38, 298-306.
- Wong N, Lam WC, Lai PB, et al (2001). Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol, 159, 465-71. https://doi.org/10.1016/S0002-9440(10)61718-X
- Winfield SL, Tayebi N, Martin BM, et al (1997). Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease. Genome Res, 7, 1020-6. https://doi.org/10.1101/gr.7.10.1020
- Yu W, Bjorn Andersson, Worley KC, et al (1997). Large-scale concatenation cDNA sequencing. Genome Res, 7, 353-8. https://doi.org/10.1101/gr.7.4.353
피인용 문헌
- Targeting SHCBP1 Inhibits Cell Proliferation in Human Hepatocellular Carcinoma Cells vol.14, pp.10, 2013, https://doi.org/10.7314/APJCP.2013.14.10.5645
- Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling vol.45, pp.2, 2014, https://doi.org/10.3892/ijo.2014.2482
- Transplantation of ATP7B–Transduced Bone Marrow Mesenchymal Stem Cells Decreases Copper Overload in Rats vol.9, pp.11, 2014, https://doi.org/10.1371/journal.pone.0111425
- Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase vol.240, pp.3, 2015, https://doi.org/10.1177/1535370214561957
- Cohort-wide deep whole genome sequencing and the allelic architecture of complex traits vol.9, pp.1, 2018, https://doi.org/10.1038/s41467-018-07070-8